MARC D. KOZIN - 20 Mar 2024 Form 4 Insider Report for CHIMERIX INC

Role: Director
Signature: /s/ Michael Alrutz, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 20 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 21 Mar 2024, 16:10:42 UTC
Previous filing: 08 Jun 2023
Next filing: 07 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRX	Stock Option (Right to Buy)	Award	$0	+100,000		$0.000000	100,000	20 Mar 2024	Common Stock	100,000	$0.9900	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-third of the shares subject to the stock option will vest and become exercisable on March 20, 2025 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter, such that the option will be fully vested on March 20, 2027, subject to Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan).

Content

One-third of the shares subject to the stock option will vest and become exercisable on March 20, 2025 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter, such that the option will be fully vested on March 20, 2027, subject to Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan).